Stock Rating Downgrade
Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Neogenomics Inc (NASDAQ: NEO) weakened recently. NEO’s current Value Trend Rating is D and the prior Rating was C. Details supporting this lower rating are included in our next report.
Recent Price Action
On 4/8/24, Neogenomics Inc (NASDAQ: NEO) stock declined slightly by -0.5%, closing at $14.85. However, unusually low trading volume at 55% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has declined -5.5% during the last week.
Current PriceTarget Research Rating
NEO is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Neogenomics has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Neogenomics has a poor Appreciation Score of 23 but a slightly positive Power Rating of 64, triggering the Negative Value Trend Rating.
Be the first to comment